Jaguar Health, Inc. (JAGX): debt financing — Jaguar Health issues $350K in 6% notes and warrants for 350K shares at $1.00

Jaguar Health, Inc.

Issued $350,000 aggregate principal amount of unsecured promissory notes to two accredited investors.
Notes bear 6% annual interest and mature one month from issuance; prepayable without penalty.
Investors received warrants to purchase up to 350,000 shares of common stock at $1.00/share, exercisable immediately for five years.
Proceeds used for working capital and general corporate purposes; transaction closed January 5, 2026.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.95

Jaguar Health, Inc. incurred senior notes of $350,000 aggregate principal amount at 6% per annum maturing one month after issuance.

Instrument: senior notes
Principal: $350,000 aggregate principal amount
Rate: 6% per annum
Maturity: one month after issuance
Event: incurrence

Exact text from the filing

On January 5, 2026 (the “Execution Date”), Jaguar Health, Inc. (the “Company”) entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors.

View on SEC.gov

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.95

Jaguar Health, Inc. issued 350,000 shares of warrant to two accredited investors for $350,000 aggregate principal amount of unsecured promissory notes.

Security: warrant
Shares: 350,000 shares
Purchaser: two accredited investors
Consideration: $350,000 aggregate principal amount of unsecured promissory notes

Exact text from the filing

entered into securities purchase agreements (the “Securities Purchase Agreements”) with two accredited investors (each, an “Investor”), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes (collectively, the “Notes”) to such Investors. The Company will use the proceeds for working capital and other general

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Jaguar Health, Inc. entered into Securities Purchase Agreements with two accredited investors valued at $350,000 (effective 2026-01-05).

Action: entry
Agreement: equity purchase
Counterparty: two accredited investors
Value: $350,000
Effective: 2026-01-05

Exact text from the filing

On January 5, 2026 (the "Execution Date"), Jaguar Health, Inc. (the "Company") entered into securities purchase agreements (the "Securities Purchase Agreements") with two accredited investors (each, an "Investor"), pursuant to which the Company issued $350,000 aggregate principal amount of unsecured promissory notes

View on SEC.gov

26 debt financings filed in the last 30 days. Browse all debt financings →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-009221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.